Futura Medical
Research Futura Medical (FUM) on Bullrun: market cap GBX 220.90M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerFUM
- ExchangeLSE
- CountryUnited Kingdom
- SectorHealthcare
- IndustryBiotechnology
- CurrencyGBX
- Market capGBX 220.90M
- Financial periodFY2025
- RevenueGBP 1.70M
- Revenue growth-87.8%
- Net income-GBP 9.07M
- Free cash flow-GBP 5.62M
- Gross margin73.1%
Valuation Snapshot
latest market cap is GBX 220.90M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | GBP 1.70M | -GBP 9.07M | -GBP 5.62M | 73.1% | -0.03 | GBP 3.40M | n/a | GBP 2.81M |
| FY2024 | GBP 13.93M | GBP 1.29M | -GBP 1.34M | 69.6% | 0 | GBP 6.60M | n/a | GBP 8.96M |
| FY2023 | GBP 3.10M | -GBP 6.51M | -GBP 935.60K | 57.2% | 0.02 | GBP 7.71M | n/a | GBP 5.48M |
| FY2022 | GBP 0 | -GBP 5.85M | -GBP 6.52M | n/a | -0.02 | GBP 4.03M | n/a | GBP 4.72M |
| FY2021 | GBP 0 | -GBP 4.96M | -GBP 4.29M | n/a | n/a | GBP 10.37M | n/a | GBP 9.72M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-29 | GBX 220.90M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 GBX.
About Futura Medical
Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company's lead product includes Eroxon, a topical treatment for erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Futura Medical's market cap?
Futura Medical's market capitalization is GBX 220.90M.
What does Futura Medical do?
Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company's lead product includes Eroxon, a topical treatment for erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.